Subjective well‐being under neuroleptic treatment and its relevance for compliance

Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia

2002 • 1,303 citations

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1983 • 993 citations

Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings

1997 • 985 citations

Why Do Schizophrenic Patients Refuse to Take Their Drugs?

1974 • 584 citations

Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?

2002 • 395 citations

'Akinetic Depression' in Schizophrenia

1978 • 388 citations

Improvement of schizophrenic patients’ subjective well-being under atypical antipsychotic drugs

2001 • 342 citations

A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables

1995 • 308 citations

Rating of Medication Influences (ROMI) Scale in Schizophrenia

1994 • 274 citations

Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability

1998 • 266 citations

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

2004 • 256 citations

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life

2000 • 229 citations

Subjective Response to Antipsychotic Drugs

1981 • 225 citations

Clinical Management of Clozapine Patients in Relation to Efficacy and Side-Effects

1992 • 181 citations

Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures

1992 • 161 citations

Subjective well-being and quality of life under atypical antipsychotic treatment

2002 • 140 citations

Clinical correlates of early medication adherence: West London first episode schizophrenia study

2003 • 133 citations

Neuroleptic dysphoria: towards a new synthesis

2004 • 129 citations

Subjective Experience and Striatal Dopamine D2 Receptor Occupancy in Patients With Schizophrenia Stabilized by Olanzapine or Risperidone

2000 • 120 citations

Subjective Experience and D₂Receptor Occupancy in Patients With Recent-Onset Schizophrenia Treated With Low-Dose Olanzapine or Haloperidol: A Randomized, Double-Blind Study

2003 • 115 citations

Facilitating compliance with antipsychotic medication.

1998 • 115 citations

Patients?? subjective experiences on antipsychotic medications: implications for outcome and quality of life

1995 • 112 citations

The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study

2002 • 111 citations

Psychomotor, Cognitive, Extrapyramidal, and Affective Functions of Healthy Volunteers During Treatment With an Atypical (Amisulpride) and a Classic (Haloperidol) Antipsychotic

1999 • 106 citations

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

2002 • 103 citations

Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight

1998 • 102 citations

Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophrenia

2005 • 100 citations

Personal evaluation of transitions in treatment (PETiT):a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia

2002 • 98 citations

Neuroleptics and the neuroleptic‐induced deficit syndrome

1994 • 96 citations

Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale

2002 • 91 citations

Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors

2000 • 87 citations

The Subjective Experience of Deficits in Schizophrenia

1988 • 86 citations

Subjective experience and mental side‐effects of antipsychotic treatment

1999 • 86 citations

New Antipsychotics, Compliance, Quality of Life, and Subjective Tolerability—Are Patients Better Off?

2004 • 81 citations

The Subjective Experience of Negative Symptoms: A self-rating scale

1993 • 78 citations

Patients?? Subjective Experiences of Antipsychotics

2002 • 72 citations

The measurement of subjective experience in schizophrenia: The subjective deficit syndrome scale

1990 • 71 citations

A longitudinal study of patient- and observer-rated quality of life in schizophrenia

2003 • 59 citations

Facilitating compliance with antipsychotic medication.

1998 • 53 citations

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.

1976 • 48 citations

Novel Antipsychotic Drugs

1993 • 48 citations

Subjective Well-being and Initial Dysphoric Reaction under Antipsychotic Drugs - Concepts, Measurement and Clinical Relevance

2003 • 45 citations

Is neuroleptic dysphoria a healthy response?

1989 • 43 citations

Subjective Response to Antipsychotics of Schizophrenia Patients Treated in Routine Clinical Practice

2004 • 41 citations

Correlation of Subjective Well-being in Schizophrenic Patients with Gait Parameters, Expert-rated Motor Disturbances, and Psychopathological Status

2005 • 36 citations

Neuropsychotherapeutics in the UK

2004 • 26 citations

Treatment with neuroleptics: the patient's perspective

1992 • 23 citations

A Simple Switching Strategy for Inadequately Treated Patients with Schizophrenia to Olanzapine: Changes in Psychopathology and Subjective Well-being

2005 • 23 citations

Is Neuroleptic Dysphoria a Variant of Drug-Induced Extrapyramidal Side Effects?

2004 • 22 citations

Introduction to Sertindole in Clinical Practice

2004 • 7 citations